PubRank

Hiroto Egawa

Author PubWeight™ 104.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transpl 2007 2.09
2 An extended dysfunctional area in the congestive area of the remnant liver after hemi-hepatectomy with middle hepatic vein resection for liver cancers evaluated on the gadoxetic acid disodium-enhanced magnetic resonance imaging. J Hepatobiliary Pancreat Sci 2013 1.97
3 Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes. J Hepatol 2006 1.89
4 Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation? Surgery 2010 1.82
5 Auxiliary partial orthotopic living donor liver transplantation: Kyoto University experience. Am J Transplant 2005 1.70
6 Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts. Liver Transpl 2012 1.67
7 Living donor liver transplantation with reduced monosegments for neonates and small infants. Transplantation 2007 1.61
8 Comprehensive and innovative techniques for liver transplantation in rats: a surgical guide. World J Gastroenterol 2010 1.57
9 Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation. Liver Transpl 2006 1.52
10 Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation. Liver Transpl 2009 1.50
11 Resistance to parathyroid hormone in two patients with familial intrahepatic cholestasis: possible involvement of the ATP8B1 gene in calcium regulation via parathyroid hormone. J Pediatr Gastroenterol Nutr 2004 1.48
12 Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma. Liver Transpl 2006 1.48
13 Anatomical variations and surgical strategies in right lobe living donor liver transplantation: lessons from 120 cases. Transplantation 2002 1.48
14 Long-term quality of life of donors after living donor liver transplantation. Liver Transpl 2012 1.47
15 Evaluation of risk for atherosclerosis in Alagille syndrome and progressive familial intrahepatic cholestasis: two congenital cholestatic diseases with different lipoprotein metabolisms. J Pediatr 2005 1.45
16 Duct-to-duct biliary reconstruction in living donor liver transplantation utilizing right lobe graft. Ann Surg 2002 1.37
17 Biliary reconstruction in right lobe living-donor liver transplantation: Comparison of different techniques in 321 recipients. Ann Surg 2006 1.35
18 Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University. Liver Transpl 2005 1.32
19 Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl 2007 1.27
20 Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients. Clin Pharmacol Ther 2006 1.20
21 Endoscopic treatment of biliary complications after right-lobe living-donor liver transplantation with duct-to-duct biliary anastomosis. J Hepatobiliary Pancreat Surg 2006 1.17
22 Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases. Ann Surg 2007 1.15
23 Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria. Dig Dis 2007 1.11
24 Surgery-related morbidity in living donors of right-lobe liver graft: lessons from the first 200 cases. Transplantation 2003 1.09
25 Intraoperative blood loss during living donor liver transplantation: an analysis of 635 recipients at a single center. Transfusion 2005 1.06
26 Living donor liver transplantation for pediatric patients with inheritable metabolic disorders. Am J Transplant 2005 1.04
27 Outcome of percutaneous transhepatic venoplasty for hepatic venous outflow obstruction after living donor liver transplantation. Radiology 2006 1.03
28 Endoscopic management of biliary strictures after duct-to-duct biliary reconstruction in right-lobe living-donor liver transplantation. Transplantation 2003 1.03
29 Impact of right lobe with middle hepatic vein graft in living-donor liver transplantation. Am J Transplant 2005 1.02
30 Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab. Transplantation 2012 1.01
31 The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience. Ther Apher Dial 2006 0.98
32 Significance of C4d staining in ABO-identical/compatible liver transplantation. Mod Pathol 2007 0.96
33 Surgery-related morbidity in living donors for liver transplantation. Transplantation 2010 0.96
34 Background and clinical impact of tissue congestion in right-lobe living-donor liver grafts: a magnetic resonance imaging study. Transplantation 2003 0.93
35 MR imaging with quantitative diffusion mapping of tacrolimus-induced neurotoxicity in organ transplant patients. Eur Radiol 2002 0.93
36 Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation. Ther Apher Dial 2005 0.92
37 Factors influencing liver regeneration following living-donor liver transplantation of the right hepatic lobe. Transplantation 2003 0.92
38 Impact of intestinal CYP2C19 genotypes on the interaction between tacrolimus and omeprazole, but not lansoprazole, in adult living-donor liver transplant patients. Drug Metab Dispos 2009 0.92
39 Hepatic venous outflow obstruction in pediatric living donor liver transplantation using left-sided lobe grafts: Kyoto University experience. Liver Transpl 2010 0.91
40 Benign hepatic nodules in Budd-Chiari syndrome: radiologic-pathologic correlation with emphasis on the central scar. AJR Am J Roentgenol 2002 0.91
41 A successful liver transplantation for refractory hepatic veno-occlusive disease originating from cord blood transplantation. Am J Transplant 2002 0.90
42 Living donor liver transplantation for acute liver failure in infants: the impact of unknown etiology. Pediatr Transplant 2008 0.89
43 Living donor liver transplantation for biliary atresia complicated by situs inversus: technical highlights. Liver Transpl 2005 0.89
44 Hepatitis B virus infection in lymphatic tissues in inactive hepatitis B carriers. J Hepatol 2005 0.89
45 Living donor liver transplantation for noncirrhotic inheritable metabolic liver diseases: impact of the use of heterozygous donors. Transplantation 2005 0.88
46 Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation. Transplantation 2009 0.87
47 Two different methods for donor hepatic transection: cavitron ultrasonic surgical aspirator with bipolar cautery versus cavitron ultrasonic surgical aspirator with radiofrequency coagulator-A randomized controlled trial. Liver Transpl 2009 0.86
48 Vascular reconstruction and complications in living donor liver transplantation in infants weighing less than 6 kilograms: the Kyoto experience. Liver Transpl 2006 0.86
49 De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation. Antivir Ther 2011 0.86
50 Progressive familial intrahepatic cholestasis: a single-center experience of living-donor liver transplantation during two decades in Japan. Clin Transplant 2010 0.85
51 Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation. Liver Transpl 2004 0.85
52 Antidonor antibody in patients receiving ABO-identical and HLA-mismatched living donor liver transplants: effect on survival. Transplantation 2007 0.85
53 The role of apheresis therapy in living donor liver transplantation. Ther Apher Dial 2004 0.85
54 Classification of human liver transplant recipients by their preoperative CD8+ T cell subpopulation and its relation to outcome. Liver Transpl 2006 0.85
55 Significance of serial real-time PCR monitoring of EBV genome load in living donor liver transplantation. Clin Transplant 2002 0.84
56 Novel virtual hepatectomy is useful for evaluation of the portal territory for anatomical sectionectomy, segmentectomy, and hemihepatectomy. J Hepatobiliary Pancreat Sci 2013 0.84
57 FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts. Am J Pathol 2007 0.84
58 Histological recurrence of autoimmune liver diseases after living-donor liver transplantation. Hepatol Res 2007 0.83
59 Living-donor liver transplantation for hepatoblastoma. Am J Transplant 2005 0.83
60 Human leukocyte antigens in Japanese patients with biliary atresia: retrospective analysis of patients who underwent living donor liver transplantation. Hum Immunol 2005 0.83
61 Serial assessment of immune status by circulating CD8 effector T cell frequencies for posttransplant infectious complications. Clin Dev Immunol 2008 0.82
62 MDR1 haplotypes conferring an increased expression of intestinal CYP3A4 rather than MDR1 in female living-donor liver transplant patients. Pharm Res 2009 0.82
63 Noninvasive ventilation for pediatric patients including those under 1-year-old undergoing liver transplantation. Liver Transpl 2005 0.82
64 In vitro infection of immortalized primary hepatocytes by HCV genotype 4a and inhibition of virus replication by cyclosporin. Microbiol Immunol 2007 0.81
65 Variations in biliary anatomy associated with trifurcated portal vein in right-lobe living-donor liver transplantation. Transplantation 2005 0.81
66 Impact of age older than 60 years in living donor liver transplantation. Transplantation 2007 0.81
67 Long-term outcomes for 32 cases of Wilson's disease after living-donor liver transplantation. Transplantation 2009 0.81
68 Living-donor liver transplantation for polycystic liver disease. Transplantation 2004 0.81
69 Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation. Transplantation 2004 0.80
70 Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan. World J Gastroenterol 2011 0.80
71 Rapid quantitation of immunoglobulin G antibodies specific for blood group antigens A and B by surface plasmon resonance. Transfusion 2005 0.80
72 Idiopathic post-transplantation hepatitis following living donor liver transplantation, and significance of autoantibody titre for outcome. Transpl Int 2008 0.80
73 Pediatric orthotopic living-donor liver transplantation cures pulmonary hypertension caused by Abernethy malformation type Ib. Pediatr Transplant 2011 0.80
74 Results of living donor liver transplantation in five children with congenital cardiac malformations requiring cardiac surgery. Pediatr Transplant 2006 0.79
75 Significance of semiquantitative assessment of preformed donor-specific antibody using luminex single bead assay in living related liver transplantation. Clin Dev Immunol 2013 0.79
76 Effects of double-filtration plasmapheresis combined with interferon plus ribavirin for recurrent hepatitis C after living donor liver transplantation. Liver Transpl 2008 0.79
77 Cytotoxic T-cell-mediated defense against infections in human liver transplant recipients. Liver Transpl 2007 0.79
78 Individualized extension of pegylated interferon plus ribavirin therapy for recurrent hepatitis C genotype 1b after living-donor liver transplantation. Transplantation 2010 0.79
79 In-hospital mortality in adult recipients of living donor liver transplantation: experience of 576 consecutive cases at a single center. Liver Transpl 2009 0.79
80 Initial burst of viremia related to CD8 effector memory T cells after living donor liver transplantation in hepatitis C virus-infected recipients. Transl Res 2010 0.79
81 A case with transient increases in serum S100A8/A9 levels implying acute inflammatory responses after pancreatic islet transplantation. Ann Clin Biochem 2007 0.78
82 The influence of intraoperative homologous blood transfusion on prognosis after liver transplantation for hepatocellular carcinoma. Hepatogastroenterology 2009 0.78
83 Analysis of complications in hepatic right lobe living donors. Ann Saudi Med 2010 0.78
84 Immediate noninvasive ventilation may improve mortality in patients with hepatopulmonary syndrome after liver transplantation. Liver Transpl 2011 0.78
85 Arteriopathy in chronic allograft rejection in liver transplantation. Liver Transpl 2004 0.78
86 Significance of trough monitoring for tacrolimus blood concentration and calcineurin activity in adult patients undergoing primary living-donor liver transplantation. Eur J Clin Pharmacol 2011 0.78
87 [Advanced gastric cancer in an elderly woman showing histopathologic CR after a course of S-1 and CDDP combination therapy]. Gan To Kagaku Ryoho 2010 0.78
88 Intragraft expression of recipient-type ABO blood group antigens: long-term follow-up and histological features after liver transplantation. Liver Transpl 2005 0.78
89 Tips for anatomical hepatectomy for hepatocellular carcinoma by the Glissonean pedicle approach (with videos). J Hepatobiliary Pancreat Sci 2014 0.78
90 Histology of intestinal allografts: lymphocyte apoptosis and phagocytosis of lymphocytic apoptotic bodies are diagnostic findings of acute rejection in addition to crypt apoptosis. Am J Surg Pathol 2013 0.78
91 Mesorenal shunt using inferior mesenteric vein and left renal vein in a case of LDLT. Transpl Int 2009 0.77
92 Endoscopic management of postoperative biliary complications in donors for living donor liver transplantation. Clin Gastroenterol Hepatol 2003 0.77
93 Liver transplantation without isoniazid prophylaxis for recipients with a history of tuberculosis. Clin Transplant 2007 0.77
94 Living-donor liver transplantation for progressive familial intrahepatic cholestasis. World J Surg 2011 0.77
95 Development of pulmonary hypertension in 5 patients after pediatric living-donor liver transplantation: de novo or secondary? Liver Transpl 2006 0.77
96 Fatal impact of lymphocyte cross-matching upon humoral rejection after adult living related liver transplantation. Transpl Int 2009 0.77
97 De novo autoimmune hepatitis affecting allograft but not the native liver in auxiliary partial orthotopic liver transplantation. Transplantation 2003 0.77
98 Characteristics of NO cycle coupling with urea cycle in non-hyperammonemic carriers of ornithine transcarbamylase deficiency. Mol Genet Metab 2013 0.76
99 Mycophenolate mofetil may induce prolonged severe anemia during pegylated-interferon/ribavirin/simeprevir therapy in liver transplant recipients. Clin J Gastroenterol 2015 0.76
100 Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system. J Gastroenterol 2013 0.76
101 Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients. Transplantation 2006 0.76
102 Crane-neck deformity after right lobe living donor liver transplantation. Gastrointest Endosc 2006 0.76
103 Monosegmental living-donor liver transplantation for infantile hepatic hemangioendothelioma. J Pediatr Surg 2003 0.76
104 The technical pitfalls of duct-to-duct biliary reconstruction in pediatric living-donor left-lobe liver transplantation: the impact of stent placement. Pediatr Transplant 2007 0.76
105 Long-term effects of liver transplantation on bone mineral density in children with end-stage liver disease: a 2-year prospective study. Liver Transpl 2003 0.76
106 Drug delivery system using microspheres that contain tacrolimus in porcine small bowel transplantation. Transpl Int 2005 0.76
107 Limited benefit of biochemical response to combination therapy for patients with recurrent hepatitis C after living-donor liver transplantation. Transplantation 2008 0.76
108 Liver retransplantation with external biliary diversion for progressive familial intrahepatic cholestasis type 1: a case report. Pediatr Transplant 2008 0.76
109 Pre-transplant risk factors predicting post-transplant cytomegalovirus infection in liver transplant recipients. Transpl Int 2007 0.76
110 The impact of meticulous management for hepatic artery thrombosis on long-term outcome after pediatric living donor liver transplantation. Clin Transplant 2008 0.76
111 Liver transplantation for congenital biliary dilatation: a single-center experience. Dig Surg 2010 0.75
112 Predictive factors for reintubation following noninvasive ventilation in patients with respiratory complications after living donor liver transplantation. PLoS One 2013 0.75
113 Human herpesvirus 6 infection in adult living related liver transplant recipients. Liver Transpl 2008 0.75
114 Inter-laboratory Variability of Current Immunoassay Methods for Tacrolimus among Japanese Hospitals. Biol Pharm Bull 2016 0.75
115 [A case of high CEA colon cancer responding to neoadjuvant chemotherapy with FOLFIRI]. Gan To Kagaku Ryoho 2010 0.75
116 Endoscopic retrieval of broken external biliary stents from the bile duct after right-lobe living-donor liver transplantation. Gastrointest Endosc 2003 0.75
117 Liver transplantation for primary hyperoxaluria type 1: a single-center experience during two decades in Japan. World J Surg 2013 0.75
118 Impact of Antibodies that React with Liver Tissue and Donor-specific anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis. Transplantation 2017 0.75
119 Successful stent placement for hepatic venous outflow obstruction in pediatric living donor liver transplantation, including a case series review. Pediatr Transplant 2008 0.75
120 Is biliary bile acid a good predictor for acute cellular rejection in living donor liver transplantation? Hepatobiliary Pancreat Dis Int 2009 0.75
121 Liver transplantation for severe hepatitis in patients with common variable immunodeficiency. Pediatr Transplant 2011 0.75
122 Apolipoprotein E (ApoE) and ApoE-rich high-density cholesterol as potential early diagnostic markers of congenital biliary tract anomalies. J Pediatr 2003 0.75
123 A new technique for intraoperative continuous biliary drainage during pancreatoduodenectomy. Dig Surg 2008 0.75
124 Factors affecting postoperative hyperbilirubinemia in the donor after living donor liver transplantation. Hepatogastroenterology 2009 0.75
125 Acute lymphoblastic leukemia after living donor liver transplantation. Pediatr Int 2005 0.75
126 Living donor liver transplantation in a recipient with anti-Fy(a) and Jk(a) antibodies. Hepatogastroenterology 2005 0.75
127 [Liver transplantation for familial hypercholesterolemia]. Nihon Rinsho 2007 0.75
128 Role of HLA compatibility in pediatric living-related liver transplantation. Transplantation 2002 0.75
129 [Posttransplant lymphoproliferative disorder]. Nihon Rinsho 2006 0.75
130 Successful neoadjuvant treatment with radiochemotherapy and systemic chemotherapy for the locally advanced pancreatic head cancer: report of a case. Hepatogastroenterology 2011 0.75
131 Frequent overlap of active hepatitis in recurrent primary sclerosing cholangitis after living-donor liver transplantation relates to its rapidly progressive course. Hum Pathol 2011 0.75
132 Living donor liver transplantation from donor with previous upper abdominal surgery. Transplantation 2005 0.75